Advertisement
Journal Home
Search for

Volume 62, Issue 12, Pages 1226-1232 (December 2009)


View previous. 4 of 18 View next.

Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships

Jeremy A. RassenabcCorresponding Author Informationemail address, M. Alan Brookhartab, Robert J. Glynnabd, Murray A. Mittlemanbce, Sebastian Schneeweissabc

Accepted 14 December 2008. published online 09 April 2009.

Abstract 

The gold standard of study design for treatment evaluation is widely acknowledged to be the randomized controlled trial (RCT). Trials allow for the estimation of causal effect by randomly assigning participants either to an intervention or comparison group; through the assumption of “exchangeability” between groups, comparing the outcomes will yield an estimate of causal effect. In the many cases where RCTs are impractical or unethical, instrumental variable (IV) analysis offers a nonexperimental alternative based on many of the same principles. IV analysis relies on finding a naturally varying phenomenon, related to treatment but not to outcome except through the effect of treatment itself, and then using this phenomenon as a proxy for the confounded treatment variable.

This article demonstrates how IV analysis arises from an analogous but potentially impossible RCT design, and outlines the assumptions necessary for valid estimation. It gives examples of instruments used in clinical epidemiology and concludes with an outline on estimation of effects.

a Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Boston, MA, USA

b Harvard Medical School, Boston, MA, USA

c Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA

d Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA

e Cardiovascular Epidemiology Research Group, Beth Israel Deaconess Medical Center, Boston, MA, USA

Corresponding Author InformationCorresponding author. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA.

PII: S0895-4356(09)00014-6

doi:10.1016/j.jclinepi.2008.12.005


View previous. 4 of 18 View next.

Advertisement